Nightstar Therapeutics company

NightstaRx Ltd. is a U.K. startup company. Gene therapy is the use of a gene to treat disease. The approach could enable treatments for a several rare conditions caused by mutations in a single gene.
Technology: Regenerative Medicine
Industry: Regenerative Medicine
Headquarters: London, England, United Kingdom
Founded Date: 7-5
Employees Number: 11-50
Funding Status: M&A
Investors Number: 4
Total Funding: $174.6M
Estimated Revenue: $1M to $10M
Last Funding Type: Post-IPO Equity

Visit Website
enquiries@nightstarx.com
@nightstar_x
Register and Claim Ownership